Page 58 - Aet News Today

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.”

Ovia Health unveiled a new fertility and family-building benefit for employers and health plans that includes financial support, care navigation services and one-on-one concierge support.

Afentra plc (LON:AET – Get Free Report) insider Gavin Wilson purchased 150,000 shares of the stock in a transaction dated Thursday, November 9th. The shares were acquired at an average cost of GBX 30 ($0.37) per share, with a total value of £45,000 ($55,548.70). Afentra Stock Performance LON:AET opened at GBX 30 ($0.37) on Monday. […]

OmniLife Health's initial focus with its complex care coordination platform is organ transplant care.

Just 37% of employees trust their insurer to suggest high-quality care regardless of cost, while 53% trust their employer with their health, according to a survey released by Included Health.

We are on the edge of rapid innovation in psychiatry. Now is the time to break out of our silos and take advantage of the promise the future holds.

Novartis gains global rights to Legend Biotech cell therapies that address DLL3, a promising target for lung cancers and other types of solid tumors. The pharmaceutical giant may make these therapies using T-Charge, its next-generation CAR T-cell therapy manufacturing technology.

A significant healthcare crisis looms as Baby Boomers age, which will contribute to a rise in Alzheimer’s cases. Combined with a shortage of geriatricians and caregivers, we will soon have more lonely seniors in America. We must open our minds to new solutions, such as robotic companions.

It’s easy to oversimplify and say, “These big tech companies are now doing healthcare and they’re going to solve everything.” But the reality is that often, the solutions are not going to come from big tech.

Digital tools like remote monitoring devices, virtual care, and clinical intelligence platforms – all can be leveraged to fill gaps in care in rural hospitals as it relates to care in neonatal intensive care units. In the hands of a collective many, they can be deployed to level the playing field in caring for babies needing special attention and to increase bandwidth and improve adherence to quality guidelines.